Managing a case of extensively drug-resistant (XDR) pulmonary tuberculosis in Singapore

Annals of the Academy of Medicine Singapore

Volumn 40, Issue 3, 2011, Pages 132-135

  Phua, Chee Kiang ^a   Chee, Cynthia B E ^a   Chua, Angeline P G ^a   Gan, Suay Hong ^a   Ahmed, Aneez D B ^a   Wang, Yee Tang ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Directly observed therapy; Multidrug resistant; Mycobacteria

Indexed keywords

AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHIONAMIDE; KANAMYCIN; LEVOFLOXACIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DEPRESSION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HEALTH CARE COST; HUMAN; HYPOTHYROIDISM; LUNG LOBECTOMY; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT ASSESSMENT; SEPSIS; SINGAPORE; SPUTUM SMEAR; THORAX RADIOGRAPHY;

EID: 79955610445     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. CDC. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-305.
2. CDC. Notice to Readers: Revised Definition of Extensively Drug-Resistant Tuberculosis. MMWR 2006;55:1176.
3. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global report on surveillance and response. 2010. Available at: http://www.who.int/tb/publications/2010/978924599191/en/ Accessed 25 Nov 2010.
4. Rüsch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006;44:688-92.
5. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. 2008. Available at: http://www.who.int/tb/publications/2008/programmatic_guidelines_for_mdrtb/en/index.html Accessed 25 Nov 2010.
6. Kang MW, Kim HK, Choi YS, Kim K, Shim YM, Koh WJ, et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010;89:1597-1602.
7. Torun T, Tahaoglu K, Ozmen I, Sevim T, Ataç G, Kir A, et al. The role of surgery and fl uoroquinolones in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2007;11:979-985.
8. Dravniece G, Cain KP, Holtz TH, Riekstina V, Leimane V, Zaleskis R. Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis. Eur Respir J 2009;34:180-183.
9. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010;375:1755-1757.
10. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Available at: http://www.who.int/tb/publications/global_report/2009/update/en/ Accessed 25 Nov 2010.
11. Jassal M, Bishai WR. Extensively drug-resistant tuberculosis. Lancet Infect Dis 2009;9:19-30.
12. Chee CB, Wang YT, Teleman MD, Boudville IC, Chew SK. Treatment outcome of Singapore residents with pulmonary tuberculosis in the first year after introduction of a computerised treatment surveillance module. Singapore Med J 2006;47:529-533.
13. Ministry of Health, Singapore. Communicable Disease Surveillance in Singapore 2008, Singapore 2009.
14. Chee CBE, Khin Mar K, Lim LKY, Cutter J, James L, Sng LH, et al. Multidrug-resistant pulmonary tuberculosis in Singapore, 2000-2006. Ministry of Health Epidemiology News Bulletin 2007;33:50-54.